the study of disease is called

Thu, 27 Nov 2014 02:07:51 GMT

The Daily Courier (subscription)

US Ebola vaccine looks protective but may require high dose: study
The Daily Courier (subscription)
The vaccine was created by scientists at the U.S. National Institute of Allergy and Infectious Diseases and is being developed by Pharma giant GSK, formerly known as GlaxoSmithKline. The study was published online Wednesday by the New England ...

and more »
Thu, 27 Nov 2014 01:14:31 GMT

CTV News

US Ebola vaccine looks protective, but may require large dose: study
CTV News
The vaccine was created by scientists at the U.S. National Institute of Allergy and Infectious Diseases and is being developed by Pharma giant GSK, formerly known as GlaxoSmithKline. The study was published online Wednesday by the New England ...

and more »
Wed, 26 Nov 2014 22:18:38 GMT

MetroNews Canada

U.S. Ebola vaccine looks protective: study
MetroNews Canada
The vaccine was created by scientists at the U.S. National Institute of Allergy and Infectious Diseases and is being developed by Pharma giant GSK, formerly known as GlaxoSmithKline. The study was published online Wednesday by the New England ...

and more »
Tue, 25 Nov 2014 08:41:25 GMT

SickKids study finds clinical pattern that may promote early diagnosis of rare ...
HealthCanal.com
An X-ray of her chest revealed that her heart was on the opposite side of her body, a condition called situs inversus. This unique finding, coupled with her respiratory problems, was an indication to doctors that she may have a rare genetic lung disease called ...

Fri, 21 Nov 2014 22:21:50 GMT

Study: Investigational Drug Reduces High Potassium Levels in Chronic Kidney ...
HealthCanal.com
... increases the risk of death in high-risk patients and limits the use of several types of drugs, called RAAS (renin-angiotensin-aldosterone system) inhibitors, commonly used to control hypertension and cardiovascular disease and prevent kidney disorders. “Patients with advanced kidney disease are at highest risk for hyperkalemia thanks to a double whammy,” says the study's principal investigator, Matthew R. Weir, MD, professor of medicine and director of the Division of Nephrology at the University of Maryland ...

and more »
Fri, 21 Nov 2014 20:38:39 GMT

Investigational Drug Reduces High Potassium Levels in Chronic Kidney Disease ...
Newswise (press release)
... a condition called hyperkalemia, increases the risk of death in high-risk patients and limits the use of several types of drugs, called RAAS (renin-angiotensin-aldosterone system) inhibitors, commonly used to control hypertension and cardiovascular disease and ... “Patients with advanced kidney disease are at highest risk for hyperkalemia thanks to a double whammy,” says the study's principal investigator, Matthew R. Weir, MD, professor of medicine and director of the Division of Nephrology at the University of ...

and more »
Thu, 20 Nov 2014 18:20:51 GMT

Diabetes Insider

Study Suggests Coronary Heart Disease Patients May Not Need Heart Valve ...
Diabetes Insider
A recent study provides pretty solid evidence that adding a mitral valve repair to the open-heart surgery procedure called coronary artery bypass grafting does not actually provide any significant benefit to the patient. In fact, contrary to what doctors had thought ...

and more »
Wed, 19 Nov 2014 18:08:56 GMT

Medical Xpress

Alzheimer's disease: Molecular signals cause brain cells to switch into a hectic ...
Medical Xpress
... normal function of neurons and are involved in the regulation of cerebral blood flow. Through experimental studies scientists of the German Center for Neurodegenerative Diseases at the Bonn and Berlin sites have now gained new insights into how Alzheimer's interferes with the metabolism of astrocytes. ... Cells located near the "plaques", as the protein deposits typical for this disease are called, grow in size and form additional extensions. However, until know it was largely unclear how these changes affect the ...

and more »
Wed, 19 Nov 2014 10:00:50 GMT

Is relief from Alzheimer's disease on the horizon?
Las Vegas Sun
The NOBLE Study, as it's called, will examine whether the new drug, T-817MA, benefits people with mild to moderate Alzheimer's disease. Alzheimer's develops when nerve cells in the brain stop functioning normally and cause changes in a person's memory, ...

and more »
Tue, 18 Nov 2014 15:46:58 GMT

Artery Disease May Threaten Patients After Heart Attack
dailyRx
Dr. Patel and colleagues studied a condition called non-infarct-related artery (non-IRA) disease. Non-IRA disease refers to blocked arteries that don't cause a heart attack. A total of 68,765 patients were enrolled in the studies. The researchers looked ...

and more »